9.1 Medication Incident Reporting, Root Cause Analysis & Continuous Quality Improvement

Medication Incident Reporting, Root Cause Analysis & Continuous Quality Improvement

Exam Tip: In the OpenExamPrep independent study guide for the PEBC Pharmacy Technician Qualifying Examination, candidates must clearly differentiate between actual medication incidents, near misses, and hazardous conditions. Pay special attention to the Just Culture decision model—distinguishing between human error, at-risk behavior, and reckless behavior—as well as the tools used in Root Cause Analysis (RCA) and prospective Failure Mode and Effects Analysis (FMEA).

---

Regulatory Framework & Canadian Medication Safety Architecture

Medication safety in Canadian pharmacy practice operates through a collaborative network of national reporting agencies, provincial pharmacy regulatory authorities (PRAs), and institutional continuous quality improvement programs:

1. Institute for Safe Medication Practices Canada (ISMP Canada): An independent, national, non-profit organization dedicated to the advancement of medication safety across all healthcare settings. ISMP Canada collects voluntary and mandatory incident reports, analyzes root causes, issues national safety bulletins, and maintains Canadian high-alert medication lists and Look-Alike Sound-Alike (LASA) safety guidelines.
2. Canadian Medication Incident Reporting and Prevention System (CMIRPS): A collaborative pan-Canadian initiative involving Health Canada, the Canadian Institute for Health Information (CIHI), and ISMP Canada. Its mandate is to collect, analyze, and disseminate data regarding medication incidents to prevent avoidable healthcare harm nationwide.
3. National System for Incident Reporting (NSIR): Developed and managed by CIHI in partnership with Health Canada, NSIR provides a secure, web-based tool for Canadian hospitals and healthcare facilities to report and analyze medication and radiation treatment incidents.
4. Provincial Continuous Quality Improvement (CQI) Mandates: Provincial colleges of pharmacy mandate structured CQI programs in community and hospital pharmacies:
   • Ontario (AIMS Program, OCP): The Assurance and Improvement in Medication Safety program requires community pharmacies to record medication incidents and near misses, report them anonymously to a national incident data repository, analyze them, and hold regular quality-improvement meetings.
   • Saskatchewan (COMPASS) and Nova Scotia (SafetyNET-Rx): Similar continuous quality improvement programs with anonymous reporting, shared learning and team safety huddles.
   • Other provinces set their own quality assurance requirements, so check the college standards where you practise.

---

Medication Incident Taxonomies & Definitions

Standardized terminology is vital for accurate reporting, data aggregation, and systemic risk mitigation. ISMP Canada and national safety standards establish clear classifications:

┌────────────────────────────────────────────────────────────────────────┐
│                     Canadian Medication Safety Spectrum                │
├──────────────────────────┬─────────────────────────────────────────────┤
│ Hazardous Condition      │ Latent risk or defect in workflow/storage   │
│ (Latent Vulnerability)   │ (e.g., look-alike vials placed adjacently)  │
├──────────────────────────┼─────────────────────────────────────────────┤
│ Near Miss / Good Catch   │ Active error occurred but was intercepted   │
│ (Intercepted Incident)   │ before reaching the patient                 │
├──────────────────────────┼─────────────────────────────────────────────┤
│ Actual Incident          │ Event reached the patient (regardless of    │
│ (Medication Error)       │ whether injury or harm resulted)            │
└──────────────────────────┴─────────────────────────────────────────────┘

1. Hazardous Condition (Latent Failure)

Any circumstance, condition, or equipment design that poses a potential risk for medication errors or adverse events, but where no active error has yet occurred. Examples include crowded dispensary storage of look-alike ophthalmic solutions, lack of secondary barcode scanners, or malfunctioning automated counting cell sensors.

2. Near Miss / Good Catch (Intercepted Error)

A medication incident that occurred during order intake, entry, compounding, or counting, but was caught and intercepted by a healthcare professional prior to dispensing or patient administration. Example: A pharmacy technician inadvertently counts hydromorphone 2 mg instead of morphine 15 mg, but catches the discrepancy during visual technical inspection before product release. Documenting near misses is critical because they highlight process vulnerabilities without causing patient harm.

3. Actual Medication Incident (Error Reaching Patient)

A preventable event that reached the patient, which may or may not cause injury. These are classified into degrees of harm:

• No Harm: Medication reached the patient, but no adverse symptoms or physiologic changes occurred (e.g., patient received one extra dose of a routine multivitamin).
• Mild Harm: Patient experienced minor symptoms or temporary discomfort requiring minimal or no clinical intervention (e.g., mild nausea from an incorrect oral antibiotic administration schedule).
• Moderate Harm: Patient suffered noticeable physiologic injury requiring medical intervention, increased monitoring, or a prolonged hospital stay (e.g., acute hypotensive episode from receiving a double dose of an antihypertensive).
• Severe Permanent Harm: Catastrophic event causing permanent impairment or bodily dysfunction (e.g., stroke, permanent organ injury).
• Fatal (Death): The medication incident directly caused or contributed to the patient's death.

---

Just Culture Philosophy: Behavior Triage & Accountability

Historically, healthcare operated under a punitive culture, where any error resulted in blaming, disciplining, or firing the individual involved. This caused staff to hide mistakes, conceal near misses, and avoid reporting. Conversely, a blameless culture refuses to hold individuals accountable even for reckless negligence.

A Just Culture, pioneered by David Marx and championed by ISMP Canada, balances systemic accountability with personal responsibility. It recognizes that competent professionals make inadvertent mistakes, but holds individuals accountable for behavioral choices:

---

Root Cause Analysis (RCA) Methodology

When a sentinel event, serious adverse incident, or repetitive pattern of near misses occurs, a pharmacy team must conduct a Root Cause Analysis (RCA). RCA is a structured, retrospective investigation designed to identify the foundational system breakdowns rather than attributing fault to frontline staff.

The Swiss Cheese Model (James Reason)

Medication errors rarely occur due to a single isolated act. In James Reason's Swiss Cheese Model, each defensive layer (prescriber order entry, technician technical verification, automated barcode scanning, pharmacist clinical verification, patient counseling) has holes representing latent defects. An error reaches the patient only when the holes align across every single defensive barrier.

Latent Defect      Latent Defect      Active Failure     Harm Reaches
(Storage Layout) ──► (Software Alert) ──► (Skipped Check) ──► Patient
   [ Hole 1 ]          [ Hole 2 ]          [ Hole 3 ]      [ INJURY ]

Core RCA Analytical Tools

1. The 5 Whys Technique: A repetitive question-asking drill used to explore cause-and-effect relationships down to foundational policies.
   • Problem: Patient received the wrong oral liquid strength (prednisolone 15 mg/5 mL instead of 5 mg/5 mL).
   • Why 1: The technician grabbed the 15 mg/5 mL stock bottle.
   • Why 2: The two strengths were stored side-by-side in identical amber bottles on the shelf.
   • Why 3: The dispensary does not have a physical separation policy for multi-strength oral liquids.
   • Why 4: Staff were unaware of ISMP Canada pediatric liquid storage alerts.
   • Why 5 (Root Cause): The pharmacy lacks a formalized onboarding procedure and annual safety policy review for high-risk oral liquid formulations.
2. Ishikawa (Fishbone) Diagram: Categorizes potential latent causes into standardized domains:
   • People: Fatigue, inadequate training, lack of familiarity with high-risk drugs.
   • Methods / Processes: Ambiguous standard operating procedures (SOPs), lack of independent double-check protocols.
   • Machines / Technology: Computer alert fatigue, uncalibrated automated counters, barcode reader lag.
   • Materials: Look-alike packaging, similar drug names, poor labeling contrast.
   • Environment / Milieu: High noise levels, frequent telephone interruptions, inadequate task lighting.
   • Measurement: Inaccurate compounding logs, unverified pediatric weight conversions.

---

Failure Mode and Effects Analysis (FMEA) & CQI Cycles

While RCA is retrospective (conducted after an error occurs), Failure Mode and Effects Analysis (FMEA) is prospective. Before introducing a new technology, automated dispensing cabinet (ADC), compounding line, or workflow change, the pharmacy team evaluates:

1. Where could the process fail? (Failure Modes)
2. Why would the failure happen? (Potential Causes)
3. What would be the consequences? (Effects)
4. What is the Risk Priority Number (RPN)? Calculated as: RPN = Severity × Occurrence Likelihood × Detectability.

Processes with elevated RPNs are re-engineered with forcing functions before clinical launch.

Plan-Do-Study-Act (PDSA) Continuous Improvement

Pharmacies implement quality fixes using the iterative PDSA framework:

• Plan: Formulate the safety objective, map current workflow, and design the intervention.
• Do: Pilot the proposed safety protocol in a controlled environment or single workstation.
• Study: Analyze incident reporting data, near-miss capture rates, and staff feedback.
• Act: Adopt the change pharmacy-wide, adjust based on metrics, or abandon ineffective steps.

Reporting Adverse Drug Reactions (NAPRA Competency 5.5.3)

Medication incidents (errors) and adverse drug reactions (ADRs) are different. An ADR can happen even when everything was done correctly.

• Canada Vigilance Program: Health Canada collects reports of suspected ADRs, including those to natural health products, through Canada Vigilance (online form, fax or mail). Reports are especially valuable for serious or unexpected reactions and for newly marketed products.
• Mandatory hospital reporting: Under Vanessa's Law (the Protecting Canadians from Unsafe Drugs Act), hospitals must report serious adverse drug reactions and medical device incidents to Health Canada within 30 days of first documenting them.
• Vaccines: Adverse events following immunization are reported to the local public health unit, which forwards them to the national surveillance system.
• Technician role: Gather the facts (patient details with consent, product, lot number, dates, the reaction), document them objectively, and pass them to the pharmacist, who assesses the reaction and completes or supports the report.